Brendel Financial Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Brendel Financial Advisors's IDXX Position: Q4 2021 in Review
Brendel Financial Advisors sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 3,883 shares — an estimated $2.42M sold.
Brendel Financial Advisors first reported a position in IDXX in Q1 2019 and held it in 11 quarters. The position peaked at $3.02M in Q4 2020. 1,106 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.
- Brendel Financial Advisors reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
- Brendel Financial Advisors sold 3,883 Idexx Laboratories shares in Q4 2021, an estimated $2.42M.
- Brendel Financial Advisors first reported a position in Idexx Laboratories in Q1 2019 and held it in 11 quarters.
- Brendel Financial Advisors's Idexx Laboratories position peaked at $3.02M in Q4 2020.
- 1,106 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.
Based on Brendel Financial Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.